Literature DB >> 17016039

Unusual extramedullary hematopoiesis in a patient receiving granulocyte colony-stimulating factor.

Simten Dagdas1, Gulsum Ozet, Guchan Alanoglu, Meltem Ayli, Ayla Gokmen Akoz, Selim Erekul.   

Abstract

A 42-year-old woman was diagnosed with myelodysplastic syndrome with fibrosis that developed bilaterally, cervical lymphadenopathy and cutaneous infiltration by trilineage extramedullary hematopoiesis after granulocyte colony-stimulating factor therapy because of severe neutropenia. Hepatosplenomegaly was not observed during her follow-up. Extramedullary hematopoiesis disappeared after growth factor therapy was stopped. Although the neutropenia was alleviated by growth factor administration, the appearance of an unusual involvement of extramedullary hematopoiesis should be kept in mind. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016039     DOI: 10.1159/000094681

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects.

Authors:  Nina A Mikirova; James A Jackson; Ron Hunninghake; Julian Kenyon; Kyle W H Chan; Cathy A Swindlehurst; Boris Minev; Amit N Patel; Michael P Murphy; Leonard Smith; Famela Ramos; Thomas E Ichim; Neil H Riordan
Journal:  J Transl Med       Date:  2010-04-08       Impact factor: 5.531

Review 2.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

3.  Amelioration of cyclophosphamide-induced myelosuppression during treatment to rats with breast cancer through low-intensity pulsed ultrasound.

Authors:  Wei Wang; Dong Luo; Junlin Chen; Jinyun Chen; Yi Xia; Wenzhi Chen; Yan Wang
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.